vs
Side-by-side financial comparison of GERON CORP (GERN) and HEALTHSTREAM INC (HSTM). Click either name above to swap in a different company.
HEALTHSTREAM INC is the larger business by last-quarter revenue ($79.7M vs $47.2M, roughly 1.7× GERON CORP). On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 7.4%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 4.7%).
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.
GERN vs HSTM — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $79.7M |
| Net Profit | $-18.4M | — |
| Gross Margin | — | — |
| Operating Margin | -29.4% | 3.0% |
| Net Margin | -39.0% | — |
| Revenue YoY | 67.1% | 7.4% |
| Net Profit YoY | 30.3% | — |
| EPS (diluted) | $-0.03 | $0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $79.7M | ||
| Q3 25 | $47.2M | $76.5M | ||
| Q2 25 | $49.0M | $74.4M | ||
| Q1 25 | $39.6M | $73.5M | ||
| Q4 24 | — | $74.2M | ||
| Q3 24 | $28.3M | $73.1M | ||
| Q2 24 | $882.0K | $71.6M | ||
| Q1 24 | $304.0K | $72.8M |
| Q4 25 | — | — | ||
| Q3 25 | $-18.4M | $6.1M | ||
| Q2 25 | $-16.4M | $5.4M | ||
| Q1 25 | $-19.8M | $4.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-26.4M | $5.7M | ||
| Q2 24 | $-67.4M | $4.2M | ||
| Q1 24 | $-55.4M | $5.2M |
| Q4 25 | — | 3.0% | ||
| Q3 25 | -29.4% | 9.9% | ||
| Q2 25 | -25.4% | 7.9% | ||
| Q1 25 | -42.2% | 6.0% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | -99.8% | 8.9% | ||
| Q2 24 | -7860.9% | 6.2% | ||
| Q1 24 | -18465.1% | 7.8% |
| Q4 25 | — | — | ||
| Q3 25 | -39.0% | 8.0% | ||
| Q2 25 | -33.4% | 7.2% | ||
| Q1 25 | -50.1% | 5.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | -93.5% | 7.8% | ||
| Q2 24 | -7639.8% | 5.8% | ||
| Q1 24 | -18220.4% | 7.2% |
| Q4 25 | — | $0.09 | ||
| Q3 25 | $-0.03 | $0.20 | ||
| Q2 25 | $-0.02 | $0.18 | ||
| Q1 25 | $-0.03 | $0.14 | ||
| Q4 24 | — | $0.16 | ||
| Q3 24 | $-0.04 | $0.19 | ||
| Q2 24 | $-0.10 | $0.14 | ||
| Q1 24 | $-0.09 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.1M | $36.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $248.7M | $354.0M |
| Total Assets | $567.4M | $520.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $36.2M | ||
| Q3 25 | $78.1M | $53.5M | ||
| Q2 25 | $77.7M | $52.1M | ||
| Q1 25 | $83.7M | $77.3M | ||
| Q4 24 | — | $59.5M | ||
| Q3 24 | $60.3M | $57.5M | ||
| Q2 24 | $116.9M | $46.1M | ||
| Q1 24 | $189.8M | $52.4M |
| Q4 25 | — | $354.0M | ||
| Q3 25 | $248.7M | $349.2M | ||
| Q2 25 | $259.5M | $350.6M | ||
| Q1 25 | $268.2M | $362.8M | ||
| Q4 24 | — | $359.4M | ||
| Q3 24 | $292.3M | $355.5M | ||
| Q2 24 | $306.7M | $349.2M | ||
| Q1 24 | $344.9M | $344.9M |
| Q4 25 | — | $520.4M | ||
| Q3 25 | $567.4M | $499.9M | ||
| Q2 25 | $555.2M | $500.1M | ||
| Q1 25 | $562.5M | $524.0M | ||
| Q4 24 | — | $510.8M | ||
| Q3 24 | $444.9M | $502.8M | ||
| Q2 24 | $449.4M | $499.6M | ||
| Q1 24 | $482.1M | $511.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.6M | $13.2M |
| Free Cash FlowOCF − Capex | — | $13.0M |
| FCF MarginFCF / Revenue | — | 16.3% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $59.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $13.2M | ||
| Q3 25 | $-13.6M | $18.0M | ||
| Q2 25 | $-27.4M | $5.0M | ||
| Q1 25 | $-48.0M | $27.1M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | $-58.9M | $19.1M | ||
| Q2 24 | $-53.5M | $6.5M | ||
| Q1 24 | $-62.3M | $20.9M |
| Q4 25 | — | $13.0M | ||
| Q3 25 | — | $17.9M | ||
| Q2 25 | — | $2.7M | ||
| Q1 25 | — | $26.0M | ||
| Q4 24 | — | $11.0M | ||
| Q3 24 | — | $18.8M | ||
| Q2 24 | $-53.7M | $6.3M | ||
| Q1 24 | $-62.9M | $20.2M |
| Q4 25 | — | 16.3% | ||
| Q3 25 | — | 23.4% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 35.4% | ||
| Q4 24 | — | 14.8% | ||
| Q3 24 | — | 25.8% | ||
| Q2 24 | -6086.6% | 8.8% | ||
| Q1 24 | -20680.3% | 27.8% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 3.1% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | 0.0% | 0.4% | ||
| Q2 24 | 23.4% | 0.2% | ||
| Q1 24 | 202.3% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.96× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 6.25× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.34× | ||
| Q2 24 | — | 1.55× | ||
| Q1 24 | — | 4.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GERN
Segment breakdown not available.
HSTM
| Subscription Services | $77.0M | 97% |
| Professional Services | $2.7M | 3% |
